Literature Survey on Decorporation of Radionuclides from the Human Body


  1. Waller, E.A.
  2. Stodilka, R.Z.
  3. Leach, K.
  4. Prud'homme-Lalonde, L.
Corporate Authors
Defence R&D Canada - Ottawa, Ottawa ONT (CAN)
The broad use of radionuclides by many industries has greatly increased the probability of events that could lead to internalized contamination. Examples include accidents and/or intentional damage to nuclear power plants or radiation therapy units in hospitals, the use of radiological dispersal weapons, and lost or stolen radionuclide sources. Developing effective countermeasures requires knowledge of the physical and chemical composition of the radionuclides, their metabolic activities within the body, and methods to expedite their elimination from the body. This report presents a summary of information pertaining to intake and decorporation of radionuclides from humans. This information would be the first step in establishing a field protocol to guide physicians in military missions. Developing such a guide requires an understanding of the dangers associated with internal radioisotope contamination, decision levels for administering therapy (risk vs. benefit) and protocols for administering therapy. As presented, this study could be used to decide what decorporation pharmaceuticals should be maintained in quantity by the military, and how to best train officers with medical responsibilities.

Il y a un résumé en français ici.

Decorporation;DU (Depleted Uranium)
Report Number
DRDC-OTTAWA-TM-2002-042 — Technical Memorandum
Date of publication
01 Apr 2002
Number of Pages
Hardcopy;CD ROM

Permanent link

Document 1 of 1

Date modified: